INSIGHTS ON DRUG DEVELOPMENT
-
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges
Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Patented Process For Intermediates Useful For Etrasimod Arginine
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
The Role Of A Consulting Firm In The IND Process
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Revolutionizing The Development, Characterization, And Manufacturing Of Peptides
Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners8/5/2026
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics9/13/2024
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
-
Transformative Innovation: Advancing Drug Development Using In Silico Modeling3/4/2026
Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS7/29/2025
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
DRUG DEVELOPMENT SOLUTIONS
-
Quickly address critical formulation issues and optimizing performance. Explore services for small molecules and synthetic peptides across oral, topical, rectal, and parenteral routes.
-
Optimize Your GC Analysis with Zebron GC Columns
Zebron GC columns are engineered with quality of analysis in mind to better support scientists' research and regulatory analysis for environmental, food safety, food quality, forensics, pharma, fuels, and specialty chemicals.
-
Discover a new system that offers high-speed camera options and versatile customization to enhance calcium oscillation analysis and streamline workflows for efficient drug discovery.
-
Color CMOS Camera K5C
The powerful, focused research choice
When small details make all the difference, the K5C microscope camera gives you the power to find them. The color CMOS camera of choice for the materials and life science research expert, the K5C helps you to distinguish, study and document the small details in high resolution.
The K5C enables you to capture high-resolution images at any magnification level due to its 20 MP CMOS sensor. You’ll get insights and results for live images fast, thanks to the frame rate of 32 fps, helping you use speed to your imaging advantage.
-
Characterize the Best-Fit Structure for Your NMR and MS Data
ACD/Structure Elucidator Suite is the industry-leading software solution for computer-assisted structure elucidation (CASE). It offers a reliable workflow and accurate results for de novo elucidation of complex organic compound structures.
Use Structure Elucidator Suite to:
- Determine structures using NMR and other analytical data
- Generate all the candidate structures that fit your NMR and MS data
- Rank the generated structures and identify the most probable one
- Determine 3D configuration from a 2D structure using NOESY/ROESY data
- Dereplicate previously identified compounds
- Search fragment databases or manually define fragments for partially known structures
- Report the final structure and add SDFiles to the prediction databases